title: Carbonic anhydrase inhibitors: an editorial.
abstract: This issue of Expert Opinion on Therapeutic Patents is dedicated to carbonic anhydrase (CA, EC 4.2.1.1) inhibitors (CAIs), a highly dynamic research topic in the last years. Several review articles and patent analyses on diuretics and antiglaucoma, antiepileptic, anti-obesity and anticancer agents belonging to the pharmacological class of the CAIs are presented, together with a review on bacterial, fungal and protozoan CAs and their inhibition as a novel means of designing anti-infectives.
authors: Claudiu T
authors: CT
authors: Supuran
mesh_terms: D000818:Animals; D002257:Carbonic Anhydrase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D002256:Carbonic Anhydrases / Q000187:drug effects* / Q000378:metabolism; D015195:Drug Design; D006801:Humans; D010330:Patents as Topic
chemical_list: D002257:Carbonic Anhydrase Inhibitors; D002256:Carbonic Anhydrases